Specialty Pharmacy

Genentech official sheds light on the current cancer drug pipeline.

HbA1C significantly decreased in adults with poorly controlled type 2 diabetes.

Findings could lead to effective new cancer treatments.

Findings may lead to safer cancer treatments without side effects harmful to the brain.

Entecavir treats chronic hepatitis B infection in adults with evidence of active viral replication.

Protein may hold key to eradicating cancer cells.

Afatinib treats patients with advanced squamous cell carcinoma of the lung that progressed after chemotherapy.

Paul Sipes, vice president of Spud Software, discusses how specialty pharmacies can benefit from the use of a data warehouse.

Long-term aspirin use may lessen colorectal cancer risk.

Dogs show promise in sniffing out melanoma, bladder, lung, breast, and ovarian cancers.

Access to high cost curative antiviral HCV drugs remains a challenge for patients.

Psoriasis treatment may improve more than just skin issues.

Research may lead to improve rheumatoid arthritis treatment.

Genetically reduced vitamin D levels could increase susceptibility to MS.

Drug shows promise treating chronic and potentially life-threatening skin disease.

Health care professionals advised to discontinue drug regimen when appropriate.

Nanotechnology may lead to breakthroughs in the treatment of several diseases.

The FDA has proposed adding a 4-letter suffix to the names of biosimilars to distinguish them from their biologic counterparts.

Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.

The 340B Program "mega-guidance" just released by the Health Resources and Services Administration (HRSA) clarifies how patients can receive deeply discounted drugs.

A significant increase in breast cancer development was found among a specific subset of women.

Recent developments in cancer treatment and research.

Beta-blockers found reduce to stress from hormones that fuel disease progression.

Study may help improve early cancer detection.

Researchers evaluate the benefits of subcutaneous methotrexate compared with the oral version.

Higher levels of physical activities leads to lower MS relapse rates.

Amgen is seeking FDA approval for etelcalcetide, the first calcimimetic agent administered intravenously after dialysis to treat secondary hyperparathyroidism in patients with chronic kidney disease.

An independent pharmacy will pay a $46,000 settlement over an alleged lack of break times for its employees.